249 related articles for article (PubMed ID: 25131716)
1. Sex differences in antinociceptive tolerance to delta-9-tetrahydrocannabinol in the rat.
Wakley AA; Wiley JL; Craft RM
Drug Alcohol Depend; 2014 Oct; 143():22-8. PubMed ID: 25131716
[TBL] [Abstract][Full Text] [Related]
2. Gonadal hormones do not alter the development of antinociceptive tolerance to delta-9-tetrahydrocannabinol in adult rats.
Wakley AA; Wiley JL; Craft RM
Pharmacol Biochem Behav; 2015 Jun; 133():111-21. PubMed ID: 25863271
[TBL] [Abstract][Full Text] [Related]
3. Cannabidiol modulation of antinociceptive tolerance to Δ
Greene NZ; Wiley JL; Yu Z; Clowers BH; Craft RM
Psychopharmacology (Berl); 2018 Nov; 235(11):3289-3302. PubMed ID: 30238130
[TBL] [Abstract][Full Text] [Related]
4. Gonadal hormone modulation of the behavioral effects of Delta9-tetrahydrocannabinol in male and female rats.
Craft RM; Leitl MD
Eur J Pharmacol; 2008 Jan; 578(1):37-42. PubMed ID: 17905227
[TBL] [Abstract][Full Text] [Related]
5. Antinociception and sedation following intracerebroventricular administration of Δ⁹-tetrahydrocannabinol in female vs. male rats.
Wakley AA; Craft RM
Behav Brain Res; 2011 Jan; 216(1):200-6. PubMed ID: 20692296
[TBL] [Abstract][Full Text] [Related]
6. Sex differences in cannabinoid 1 vs. cannabinoid 2 receptor-selective antagonism of antinociception produced by delta9-tetrahydrocannabinol and CP55,940 in the rat.
Craft RM; Wakley AA; Tsutsui KT; Laggart JD
J Pharmacol Exp Ther; 2012 Mar; 340(3):787-800. PubMed ID: 22182934
[TBL] [Abstract][Full Text] [Related]
7. Age-related differences in Δ⁹-tetrahydrocannabinol-induced antinociception in female and male rats.
Craft RM; Britch SC; Buzitis NW; Clowers BH
Exp Clin Psychopharmacol; 2019 Aug; 27(4):338-347. PubMed ID: 31120286
[TBL] [Abstract][Full Text] [Related]
8. Sex differences in acute delta-9-tetrahydrocannabinol (Δ
Lulek CF; Maulik M; Mitra S; Guindon J; Morgan DJ; Henderson-Redmond AN
Psychopharmacology (Berl); 2023 Sep; 240(9):1987-2003. PubMed ID: 37516707
[TBL] [Abstract][Full Text] [Related]
9. Combined Treatment with Morphine and Δ9-Tetrahydrocannabinol in Rhesus Monkeys: Antinociceptive Tolerance and Withdrawal.
Gerak LR; France CP
J Pharmacol Exp Ther; 2016 May; 357(2):357-66. PubMed ID: 26937020
[TBL] [Abstract][Full Text] [Related]
10. Gonadal hormone modulation of ∆
Craft RM; Haas AE; Wiley JL; Yu Z; Clowers BH
Pharmacol Biochem Behav; 2017 Jan; 152():36-43. PubMed ID: 27670094
[TBL] [Abstract][Full Text] [Related]
11. Characterization of anandamide- and fluoroanandamide-induced antinociception and cross-tolerance to delta 9-THC after intrathecal administration to mice: blockade of delta 9-THC-induced antinociception.
Welch SP; Dunlow LD; Patrick GS; Razdan RK
J Pharmacol Exp Ther; 1995 Jun; 273(3):1235-44. PubMed ID: 7791096
[TBL] [Abstract][Full Text] [Related]
12. Cyclic ovarian hormone modulation of supraspinal Δ9-tetrahydrocannabinol-induced antinociception and cannabinoid receptor binding in the female rat.
Wakley AA; McBride AA; Vaughn LK; Craft RM
Pharmacol Biochem Behav; 2014 Sep; 124():269-77. PubMed ID: 24951841
[TBL] [Abstract][Full Text] [Related]
13. Sex differences in anti-allodynic, anti-hyperalgesic and anti-edema effects of Δ(9)-tetrahydrocannabinol in the rat.
Craft RM; Kandasamy R; Davis SM
Pain; 2013 Sep; 154(9):1709-1717. PubMed ID: 23707295
[TBL] [Abstract][Full Text] [Related]
14. Low dose combination of morphine and delta9-tetrahydrocannabinol circumvents antinociceptive tolerance and apparent desensitization of receptors.
Smith PA; Selley DE; Sim-Selley LJ; Welch SP
Eur J Pharmacol; 2007 Oct; 571(2-3):129-37. PubMed ID: 17603035
[TBL] [Abstract][Full Text] [Related]
15. No antinociceptive synergy between morphine and delta-9-tetrahydrocannabinol in male and female rats with persistent inflammatory pain.
Britch SC; Craft RM
Behav Pharmacol; 2021 Dec; 32(8):630-639. PubMed ID: 34561365
[TBL] [Abstract][Full Text] [Related]
16. The impact of gonadal hormones on cannabinoid dependence.
Marusich JA; Craft RM; Lefever TW; Wiley JL
Exp Clin Psychopharmacol; 2015 Aug; 23(4):206-16. PubMed ID: 26237318
[TBL] [Abstract][Full Text] [Related]
17. Sex-specific mechanisms of tolerance for the cannabinoid agonists CP55,940 and delta-9-tetrahydrocannabinol (Δ
Henderson-Redmond AN; Sepulveda DE; Ferguson EL; Kline AM; Piscura MK; Morgan DJ
Psychopharmacology (Berl); 2022 May; 239(5):1289-1309. PubMed ID: 34165606
[TBL] [Abstract][Full Text] [Related]
18. Cannabidiol-Δ
Britch SC; Wiley JL; Yu Z; Clowers BH; Craft RM
Drug Alcohol Depend; 2017 Jun; 175():187-197. PubMed ID: 28445853
[TBL] [Abstract][Full Text] [Related]
19. Antinociceptive and Immune Effects of Delta-9-Tetrahydrocannabinol or Cannabidiol in Male Versus Female Rats with Persistent Inflammatory Pain.
Britch SC; Goodman AG; Wiley JL; Pondelick AM; Craft RM
J Pharmacol Exp Ther; 2020 Jun; 373(3):416-428. PubMed ID: 32179573
[TBL] [Abstract][Full Text] [Related]
20. Importance of sex and relative efficacy at the mu opioid receptor in the development of tolerance and cross-tolerance to the antinociceptive effects of opioids.
Barrett AC; Cook CD; Terner JM; Craft RM; Picker MJ
Psychopharmacology (Berl); 2001 Nov; 158(2):154-64. PubMed ID: 11702089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]